Symptom burden in inflammatory bowel disease: Rethinking conceptual and theoretical underpinnings

International Journal of Nursing Practice

Volumn 16, Issue 5, 2010, Pages 437-442

  Farrell, Dawn ^a   Savage, Eileen ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Discussion paper; Inflammatory bowel disease; Symptom burden; Theory of unpleasant symptoms

Indexed keywords

ARTICLE; ENTERITIS; EVIDENCE BASED MEDICINE; HUMAN; NURSING; PATHOPHYSIOLOGY;

EVIDENCE-BASED MEDICINE; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 77956856608     PISSN: 13227114     EISSN: 1440172X     Source Type: Journal    
DOI: 10.1111/j.1440-172X.2010.01867.x     Document Type: Article

References (33)

1. Sicilia B, Vicente R, Gomollon F. Epidemiology of inflammatory bowel disease: Controversies in classical epidemiology. Acta Gastroenterologica Latinoamericana 2009, 39:135-145.
2. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
3. Gapstur RL. Symptom burden: A concept analysis and implications for oncology nursing. Oncology Nursing Forum 2007, 34:673-680.
4. Armstrong TS. Symptom experience: A concept analysis. Oncology Nursing Forum 2003, 30:601-606.
5. Dodd M, Janson S, Facione N. Advancing the science of symptom management. Journal of Advanced Nursing 2001, 33:668-676.
6. Barsevick AM. The exclusive concept of the symptom cluster. Oncology Nursing Forum 2007, 34:971-980.
7. Kim H-J, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: Concept analysis and clinical implications for cancer nursing. Cancer Nursing 2005, 28:270-282.
8. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum 2001, 28:465-470.
9. Burkett VS, Cleeland CS. Symptom burden in cancer survivorship. Journal of Cancer Survivorship 2007, 1:167-175.
10. Lenz ER, Suppe F, Gift AG, Pugh LC, Milligan RA. Collaborative development of the middle-range theory: Toward a theory of unpleasant symptoms. Advances in Nursing Science 1995, 17:1-13.
11. Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F. The middle-range theory of unpleasant symptoms: An update. Advances in Nursing Science 1997, 19:14-27.
12. Walker LO, Avant KC. Strategies for Theory Construction in Nursing 2005, Upper Saddle River, NJ, USA, Pearson/Prentice Hall
13. Lenz ER, Pugh LC. Theory of unpleasant symptoms. Middle Range Theory for Nursing 2003, 89-123. Smith MJ, Lehir PR. In, eds, New York, Springer Publishing Company
14. Sandborn W, Feagan BG, Hanauer SB. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002, 122:512-530.
15. D'Haens G, Sandborn WJ, Feagan BG. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132:763-786.
16. Bernklev T, Jahnsen J, Aadland E. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scandinavian Journal of Gastroenterology 2004, 39:365-373. the IBSEN Study Group
17. Zimmerman J. Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: Nature, severity and relationship to gastrointestinal symptoms. Digestive Diseases and Sciences 2003, 48:73-749.
18. Timmer A, Kemptner D, Takses A, Klebl F, Jockel K-H. A survey-based index was validated for measuring disease activity in inflammatory bowel disease: An evaluation study. Journal of Clinical Epidemiology 2009, 62:771-778.
19. Joyce JC, Akbar KW, Khan T. Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to change in disease activity. Health and Quality of Life Outcome 2008, 6:69.
20. Hjortswang H, Jarnerot G, Curman B. The Short Health Scale: A valid measure of subjective health in ulcerative colitis. Scandinavian Journal of Gastroenterology 2006, 41:1196-1203.
21. Haapamaki J, Turunen U, Roine RP, Farkkila MA, Arkkila PET. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey. Scandinavian Journal of Gastroenterology 2008, 43:821-830.
22. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Archives of Disease in Childhood 2003, 88:995-1000.
23. Savard J, Woodgate R. Young peoples' experience of living with ulcerative colitis and an ostomy. Gastroenterology Nursing 2009, 32:33-41.
24. Lynch T, Spence D. A qualitative study of youth living with Crohn disease. Gastroenterology Nursing 2007, 31:224-230.
25. De Rooy EC, Toner BB, Maunder RG. Concerns of patients with inflammatory bowel disease: Results from a clinical population. American Journal of Gastroenterology 2001, 96:1816-1821.
26. Daniel JM. Young adults' perceptions of living with chronic inflammatory bowel disease. Gastroenterology Nursing 2001, 25:83-94.
27. Sawicki GS, Sellers DE, Robinson WM. Self-reported physical and psychological symptom burden in adults with cystic fibrosis. Journal of Pain and Symptom Management 2008, 35:372-380.
28. Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. European Journal of Cardiovascular Nursing 2005, 4:198-206.
29. Portenoy RK, Thaler HT, Kornblith AB. Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research 1994, 3:183-189.
30. Zaman MS, Robsen KM, Lembo AJ. Overlap of irritable bowel syndrome (IBS) symptoms in patients with inflammatory bowel disease. American Journal of Gastroenterology 2002, 97:S284.
31. Nordin K, Pahlman K, Larsson K, Sundberg-Hjelm M, Loof L. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2002, 37:450-457.
32. Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. American Journal of Gastroenterology 2002, 97:1994-1999.
33. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys. Inflammatory Bowel Diseases 2006, 12:697-707.